Zapping tumors and boosting immunity: new hope for tough pancreatic cancer
NCT ID NCT03080974
Summary
This study is testing a two-part treatment for advanced pancreatic cancer that cannot be removed by surgery. First, doctors use a procedure called irreversible electroporation, which uses electrical pulses to destroy the tumor. After that, patients receive an immunotherapy drug called nivolumab, which aims to help the body's immune system fight any remaining cancer cells. The main goals are to see if this combination is safe and if it can help patients live longer without their cancer getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Louisville
RECRUITINGLouisville, Kentucky, 40202, United States
Conditions
Explore the condition pages connected to this study.